Therapeutic Photobiomodulation and Tretament of Spasticity
A legfontosabb adatok
- Ki végzi
- University of Nove de Julho
- Hol
- Brazília1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Fázis
- 2/3. fázis
- Résztvevők
- 12 fő vett részt
- Kezdés
- 2023. aug. 15.
- Befejezés
- 2024. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Photobiomodulation
- Institution's Standard Physiotherapy
- Photobiomodulation Placebo
- A regiszteradat frissítve
- 2026. május 1.
Ki vehet részt
- Életkor
- 2 év – 18 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 12 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with diagnosis of spastic cerebral palsy affecting inferior limbs from any etiology
- Cerebral palsy duration at least 03 months
- Patients ongoing physiotherapy treatment at University
Ki nem vehet részt
- Patients using topical photosensitizing medications or creams
- Patients who present acute clinical conditions with potential for increase spasticity such as acute fractures, skin ulcers, acute infections
- Patients with severe gastroesophageal reflux disease
- Patients with another type of movement or tone disorder
- Patients with a history of photosensitivity to photonic or light therapy
- Patients with fixed anatomical deformities of the ankle that do not allow ankle joint movement of at least 90 degrees of amplitude
- Patients with malnutrition
- Patients who have exposed tumors in the area to be irradiated
- Patients who have undiagnosed lesions in the treatment region
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Cerebral palsy is a non-progressive, permanent syndrome that occurs in childhood and is accompanied by motor, tônus and posture disorders. Its etiology is related to an insult or damage to the central nervous system in maturation. Approximately 80% of cerebral palsy course with spasticity, which, when left untreated, will generate pain and functional, anatomical and structural changes, with a negative impact. Photobiomodulation therapy has biological effects of tissue regeneration, muscle relaxation, vasodilation, reduction of the inflammatory process and relief of pain symptoms already described in the literature, in addition to being feasible, practical, safe, without side effects, painless and non-invasive.This study is a blind, randomized and controlled clinical trial that will evaluate the effect of photobiomodulation in reducing gastrocnemius muscle spasticity in children aged 2 to 18 years, diagnosed with spastic cerebral palsy of lower limbs of any etiology for at least 03 months and randomized into two groups: application of Low Intensity LED Therapy in the medial and right lateral gastrocnemius muscles (device power of 100mW, wavelength of 850nm, energy of 3J/cm2/point, once a week, making 08 therapeutic days during 02 months) or placebo group Low-Intensity LED Therapy (same device turned off). Both groups will also receive the standard treatment for spasticity. To assess the response to therapy, the outcomes evaluated will be the modified Ashworth Scale, the Mobility Domain of Pediatric evaluation of disability inventory, the Gross Motor Function Classification System scale and passive and active range of motion of the ankle analyzed at the pré and post each therapeutic session and in the pre and post therapeutic period of 08 sessions.
A vizsgálat 2 csoportja
- Photobiomodulation (PBM) Treatment GroupA vizsgált kezelés
Photobiomodulation therapy sessions will be carried out in the physiotherapy environment on the University, once a week, for 08 consecutive weeks in the same day of the institution's standard physiotherapy session that the patient already uses regularly (not linked to the study). will be transcutaneously, punctual application of the LED in the medial and lateral gastrocnemius muscles of the right lower limb, in contact mode, 3J/cm2, with a 850nm wavelenght (01 point per gastroc, muscle). All patients will received the PBM protocol + the standard physiotherapy rehabilitation treatment of the institute not linked to the study, and which the patient already uses regularly.
Kezelés: Photobiomodulation és Institution's Standard Physiotherapy
- Photobiomodulation (PBM) Placebo GroupPlacebo, összehasonlításként
PBM placebo therapy sessions will be carried out with the same characteristics of PBM treatment Group but with device turned off. All patients will received also the standard physiotherapy rehabilitation treatment of the institute not linked to the study, and which the patient already uses regularly.
Kezelés: Institution's Standard Physiotherapy és Photobiomodulation Placebo
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Photobiomodulation in the Treatment of Spasticity in Children With Cerebral Palsy. A Controlled, Randomized, Blind Study
- A regiszteradat frissítve
- 2026. május 1.